MARTHA RUMBLE: Open Payments
NPI 1811547201 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 25 payments from 12 companies in 2025. Trend: 2023 $1,633 · 2024 $616 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $84 |
| ABBVIE INC. | 3 | $67 |
| Braeburn Inc. | 3 | $65 |
| Alkermes, Inc. | 2 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Indivior Inc. | 2 | $36 |
| Corium, LLC | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: Auvelity, VRAYLAR, BRIXADI, VIVITROL, REXULTI, CAPLYTA, TRINTELLIX, SUBLOCADE.
Industry payments across TN — which companies pay providers there.
